Skip to main content
. 2022 Dec 29;8(1):1410–1429. doi: 10.1021/acsomega.2c06871

Table 2. Antibacterial Activity Results of the Final Compounds (μg/mL)a.

2.2.

a

RF-1: chloramphenicol, RF-2: ciprofloxacin, A: Escherichia coli ATCC 35218, B: E. coli ATCC 25922, C: Staphylococcus aureus ATCC 6538, D: methicillin-resistant S. aureus (MRSA) (clinical isolate), E: Salmonella typhimurium ATCC 13311, F: Klebsiella pneumoniae NCTC 9633. Most active compounds are highlighted in red and moderately active compounds are written in bold.